Löfhede Helena, Wertsén Madeleine, Havstam Christina
Department of Otorhinolaryngology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Sahlgrenska Academy, Speech and Language Pathology Unit, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
Head Neck. 2020 Aug;42(8):1882-1892. doi: 10.1002/hed.26124. Epub 2020 Feb 27.
Negative side effects affecting articulation and oral transport are common after treatment for head and neck cancer (HNC). The aim of this study was to assess the effects on speech and patient-reported experience of palatal augmentation prostheses (PAP) in this patient group.
Twenty consecutive patients who had received a PAP were included. We performed a blinded randomized listener assessment of recordings of the patients' speech with and without the PAP. Patient-reported experiences were collected from medical records.
The listener assessment showed that production of velar sounds improved significantly for 12 of 19 patients; 12 of 19 patients also reported easier or better speech with the PAP. All six patients treated for tongue cancer reported speech improvement. Seven of 20 patients reported better transport of food or saliva.
A PAP can help patients treated for HNC to more precisely articulated velar consonants and can benefit oral transport.
头颈部癌（HNC）治疗后，影响发音和口腔运输的负面副作用很常见。本研究的目的是评估腭部增高假体（PAP）对该患者群体言语及患者报告体验的影响。
纳入连续20例接受PAP治疗的患者。我们对患者佩戴和不佩戴PAP时的语音录音进行了盲法随机听众评估。从病历中收集患者报告的体验。
听众评估显示，19例患者中有12例软腭音的发音有显著改善；19例患者中有12例也报告佩戴PAP时言语更轻松或更好。所有6例接受舌癌治疗的患者均报告言语有所改善。20例患者中有7例报告食物或唾液的运输情况更好。
PAP可帮助接受HNC治疗的患者更精确地发出软腭辅音，并有利于口腔运输。
